Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Published in: Abdominal radiology (New York) (2022)

Overall, the TACE + MWA subcohort had the best efficacy and outcomes, especially for younger patients (less than 60-year-old) with tumor size of ≤ 3 cm, compared with the TACE + RFA or TACE + CRA subcohorts.

Keyphrases

radiofrequency ablation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
type diabetes
adipose tissue
metabolic syndrome
liver metastases
patient reported